Current Cancer Drug Targets

1.7k papers and 49.5k indexed citations i.

About

The 1.7k papers published in Current Cancer Drug Targets in the last decades have received a total of 49.5k indexed citations. Papers published in Current Cancer Drug Targets usually cover Molecular Biology (926 papers), Oncology (543 papers) and Cancer Research (317 papers) specifically the topics of Cancer, Hypoxia, and Metabolism (92 papers), Cancer, Lipids, and Metabolism (84 papers) and Cancer Research and Treatments (80 papers). The most active scholars publishing in Current Cancer Drug Targets are Lidija Klampfer, Simone Fulda, Q. Ping Dou, Yong Lin, Ranxin Shi, Han‐Ming Shen, Xia Wang, Bing‐Hua Jiang, Min Liang and Gerhard Fritz.

In The Last Decade

Fields of papers published in Current Cancer Drug Targets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Current Cancer Drug Targets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Current Cancer Drug Targets.

Countries where authors publish in Current Cancer Drug Targets

Since Specialization
Citations

This map shows the geographic impact of research published in Current Cancer Drug Targets. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Current Cancer Drug Targets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Current Cancer Drug Targets more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2025